SAMANTHA HORN: Open Payments
NPI 1144979121 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$153 in 8 payments from 6 companies in 2025. Trend: 2023 $305 · 2024 $731 · 2025 $153
Food & beverage: $153
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| EMD Serono, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| KYOWA KIRIN, INC. | 1 | $14 |
Products named: XTANDI, KEYTRUDA, ULTOMIRIS, ZEJULA, POTELIGEO.
Industry payments across IN — which companies pay providers there.
